837 results on '"Black, Henry R"'
Search Results
2. Prehypertension and Cardiovascular Disease Risk in the Women’s Health Initiative
3. Calcium Plus Vitamin D Supplementation and the Risk of Colorectal Cancer
4. Calcium plus Vitamin D Supplementation and the Risk of Fractures
5. Low-Fat Dietary Pattern and Risk of Colorectal Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial
6. Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial
7. CCR Translation for the Article from Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
8. Data from Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
9. Treatment of Hypertension in Patients with Coronary Artery Disease. A Case-Based Summary of the 2015 AHA/ACC/ASH Scientific Statement
10. Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins: A Phase 2, Open-Label, Multicenter, Dose-Titrating Study
11. Treatment of hypertension in patients with coronary artery disease: A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension
12. Lack of blood pressure difference by race in professional American football players
13. Treatment: special conditions: Resistant hypertension
14. Goal-Oriented Hypertension Management in Diabetic and Nondiabetic Patients
15. Special Situations in the Management of Hypertension
16. Studies Justifying the Use of Treatment to Prevent Cardiovascular Events
17. Special Situations in the Management of Hypertension
18. Hypertension — Diagnosis And Treatment
19. Comparative efficacy and safety of combination aliskiren/amlodipine and amlodipine monotherapy in African Americans with stage 2 hypertension and obesity or metabolic syndrome
20. Older Blood Pressure Medications—Do They Still Have a Place?
21. Insulin-A Risk Factor for Cardiovascular Disease?
22. Effects of the Chronotherapeutic Delivery of Verapamil on Circadian Blood Pressure in African-American Patients With Hypertension
23. Predicting age- and dose-related responses to antihypertensive therapy: pooled analysis of two randomized clinical trials of valsartan alone and combined with hydrochlorothiazide
24. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
25. Valsartan: More Than a Decade of Experience
26. Pharmacologic considerations in the positioning of β-blockers in antihypertensive therapy
27. Expanding the definition of hypertension to incorporate global cardiovascular risk
28. Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial
29. The Antihypertensive and Lipid Lowering reatment to prevent Heart Attack Trial (ALLHAT) heart failure validation study: diagnosis and prognosis
30. Preface
31. Dedication
32. Contributors
33. Resistant Hypertension
34. Acknowledgments
35. U.S. and Canadian Hypertension Guidelines
36. Angiotensin Receptor Blockers
37. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) heart failure Validation Study: Diagnosis and prognosis
38. Feasibility of treating prehypertension with an angiotensin-receptor blocker
39. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
40. Calcium plus vitamin D supplementation and risk of colorectal cancer
41. The prognostic value of a nomogram for exercise capacity in women
42. A global view of atherothrombosis: Baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
43. Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data
44. In Response
45. Estrogen plus progestin and the risk of coronary heart disease
46. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report
47. Principle results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial
48. ASSOCIATION OF CLINICAL RESEARCHERS AND EDUCATORS A STATEMENT ON RELATIONSHIPS BETWEEN PHYSICIANS AND INDUSTRY
49. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease
50. Acknowledgments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.